Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-19-005313

Chairman sold 27,725 shares at an average $58.83 ($1,630,931)

  • Chairman gave up 7,878 shares (to pay taxes)
  • Chairman acquired 25,946 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-26 Sale : show line 1 in the form −10,369 $59.65 $618,511 1,478,306 D
2019-02-26 Exercise or conversion : show line 2 in the form +6,430 1,484,736 D
2019-02-26 Shares withheld for taxes : show line 3 in the form −1,566 $61.01 $95,542 1,483,170 D
2019-02-27 Sale : show line 4 in the form −10,369 $58.24 $603,891 1,472,801 D
2019-02-27 Exercise or conversion : show line 5 in the form +9,794 1,482,595 D
2019-02-27 Shares withheld for taxes : show line 6 in the form −2,486 $57.98 $144,138 1,480,109 D
2019-02-28 Sale : show line 7 in the form −6,987 $58.47 $408,530 1,473,122 D
2019-02-28 Exercise or conversion : show line 8 in the form +9,722 1,482,844 D
2019-02-28 Shares withheld for taxes : show line 9 in the form −3,826 $58.71 $224,624 1,479,018 D
Open-market sales · 27,725 sh · avg $58.83 · $1,630,931

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2019-02-26 Exercise or conversion : show line 10 in the form Restricted Stock Units −6,430 42,168 D
2019-02-26 Grant or award : show line 11 in the form Restricted Stock Units +18,029 60,197 D
2019-02-26 Grant or award : show line 12 in the form Stock Options (Right to Buy) +36,053 36,053 D
2019-02-27 Exercise or conversion : show line 13 in the form Restricted Stock Units −9,794 50,403 D
2019-02-28 Exercise or conversion : show line 14 in the form Restricted Stock Units −9,722 40,681 D
Loading xslF345X03/doc4.xml…